NCT05773300

Active Not Recruiting

Registry for Mayo Clinic Adult Congenital Heart Disease Cont...

Mayo Clinic Source

Compare

Other study identifiers

Sponsor study identifier

21-011938

Secondary identifiers

R01HL158517

NIH

Study Type

observational

Actual enrollment (reported)

66

Locations

1 country

Sites

1

Timeline

Study Start

January 6, 2022

Actual (reported)

Primary Completion

December 2026

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Study Completion

December 2026

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Brief Summary

This research study is being done to provide comparative data to the Mayo Clinic Adult Congenital Heart Disease Registry.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: active not recruiting
Actual enrollment (reported): 66 participants
Study completion date: December 2026
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 6, 2022
Actual (reported)
First Submitted
March 10, 2023
Actual (reported)
First Posted
March 17, 2023
Actual (reported)
Primary Completion
December 2026
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 2026
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.

Last Updated: March 12, 2026
Status Verified: March 2026
Last Update Submitted: March 10, 2026

Conditions

Healthy

Outcome Measures

Primary Outcomes (2)

Peak Oxygen Uptake
Peak Oxygen Uptake (L/min) : 1.7 ± 0.1
6 Months
Peak Right Ventricular - Pulmonary Coupling
Peak Right Ventricular - Pulmonary Coupling: (\|%\|/mmHg): 0.786 ± 0.065
6 Months

Eligibility Criteria

Age18 Years - 70 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Subjects will be healthy individuals with no history of cardiovascular disease selected from Mayo Clinic in Rochester, Minnesota.

You may qualify if:

BMI ≤ 30.

Sponsors & Collaborators

National Heart, Lung, and Blood Institute (NHLBI)
NIHcollaborator
Mayo Clinic
Otherlead
National Institutes of Health (NIH)

Study Sites (1)

Mayo Clinic Minnesota

Rochester, Minnesota, 55905, United States

Biospecimen

Retention: SAMPLES WITHOUT DNA

2x1ml Whole Blood, 4x1mL plasma

Study Officials

Alexander Egbe, MBBS, MPH
Mayo Clinic
PRINCIPAL INVESTIGATOR

Enrollment

66 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Target Duration: 6 Months
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Principal Investigator

Study Record Dates

First Submitted

March 10, 2023

First Posted

March 17, 2023

Study Start

January 6, 2022

Actual (reported)

A Study to Evaluate Non-significant Risk Operation Magnetic Resonance Imaging for MRI Guided Ablation

Not ApplicableRecruiting

NCT05093400

Oropharynx (OPX) Salivary Biomarker Study

Completed

NCT05041192

The Effects of Synaquell on Brain Function

Not ApplicableCompleted

NCT05034913

Digital Photography to Estimate Anthropometric Measurements in Children

Not ApplicableTerminated

NCT05333263

A Study to Validate Treadmill Parameters

Not ApplicableCompleted

NCT05221918

A Study to Compare CSF Flow Metrics Across Platforms

Completed

No current cardiac medications.

Systolic BP ≤ 140 mmHg.

Diastolic BP ≤ 90 mmHg.

Capacity to consent.

You may not qualify if:

To be assessed via EMR screening.
Patient confirmation during screening visit.
Screening tests as applicable.
History of cardiovascular disease. eGFR \< 30.
Current orthopedic limitations.

Contact the study team to confirm eligibility.

NIHcollaborator

Primary Completion

December 2026

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Study Completion

December 2026

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Last Updated

March 12, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT05773300
Data provider: ClinicalTrials.gov
Source updated: 2026-03-12
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:40:48 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations